Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
West Pharmaceutical Services ( (WST) ) has shared an announcement.
On April 23, 2026, West Pharmaceutical Services reported a strong start to 2026, with first-quarter net sales rising 21.0% year over year to $844.9 million and organic growth of 15.3%, while diluted EPS jumped 56.1% to $1.92 and adjusted-diluted EPS climbed 46.9% to $2.13. Growth was led by the Proprietary Products segment, particularly High-Value Product components and delivery devices tied to GLP-1 and other therapies, and supported by the renamed West Vantage segment, prompting the company to raise full-year 2026 revenue guidance to $3.295 billion–$3.350 billion and adjusted EPS guidance to $8.40–$8.75, alongside new second-quarter sales and earnings targets and ongoing capital investment and share repurchases.
The most recent analyst rating on (WST) stock is a Hold with a $275.00 price target. To see the full list of analyst forecasts on West Pharmaceutical Services stock, see the WST Stock Forecast page.
Spark’s Take on WST Stock
According to Spark, TipRanks’ AI Analyst, WST is a Outperform.
The score is driven mainly by strong financial quality (low leverage, solid cash generation) and a supportive earnings outlook with margin expansion and EPS growth guidance. These positives are tempered by a high valuation (P/E ~36.9 with a low dividend yield) and mixed technical signals with negative MACD and price below key mid-term moving averages.
To see Spark’s full report on WST stock, click here.
More about West Pharmaceutical Services
West Pharmaceutical Services, Inc., headquartered in Exton, Pa., is a leading provider of innovative, high-quality injectable drug delivery components and devices, serving established and emerging biopharmaceutical developers worldwide. The company operates more than 50 sites, including 26 manufacturing facilities, employs over 10,000 people, delivers more than 41 billion components and devices annually, and generated $3.07 billion in net sales in fiscal 2025.
Average Trading Volume: 942,663
Technical Sentiment Signal: Buy
Current Market Cap: $19.79B
See more insights into WST stock on TipRanks’ Stock Analysis page.